Yuan Yuan

Summary

Affiliation: Loma Linda University
Country: USA

Publications

  1. pmc Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
    Yuan Yuan
    Division of Medical Oncology and Hematology, Loma Linda University Medical Center, Loma Linda, CA 92354, USA
    J Hematol Oncol 4:16. 2011

Detail Information

Publications1

  1. pmc Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
    Yuan Yuan
    Division of Medical Oncology and Hematology, Loma Linda University Medical Center, Loma Linda, CA 92354, USA
    J Hematol Oncol 4:16. 2011
    ..Olaparib, another oral small-molecule PARP inhibitor, demonstrated encouraging single-agent activity in patients with advanced breast or ovarian cancer. There are 5 other PARP inhibitors currently under active clinical investigation...